316 related articles for article (PubMed ID: 12545156)
21. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
22. Regulation of TGFbeta1-mediated growth inhibition and apoptosis by RUNX2 isoforms in endothelial cells.
Sun L; Vitolo MI; Qiao M; Anglin IE; Passaniti A
Oncogene; 2004 Jun; 23(27):4722-34. PubMed ID: 15107836
[TBL] [Abstract][Full Text] [Related]
23. c-Myc represses the proximal promoters of GADD45a and GADD153 by a post-RNA polymerase II recruitment mechanism.
Barsyte-Lovejoy D; Mao DY; Penn LZ
Oncogene; 2004 Apr; 23(19):3481-6. PubMed ID: 15021909
[TBL] [Abstract][Full Text] [Related]
24. Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3.
Gartel AL; Ye X; Goufman E; Shianov P; Hay N; Najmabadi F; Tyner AL
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4510-5. PubMed ID: 11274368
[TBL] [Abstract][Full Text] [Related]
25. Flt3 mutation activates p21WAF1/CIP1 gene expression through the action of STAT5.
Takahashi S; Harigae H; Kaku M; Sasaki T; Licht JD
Biochem Biophys Res Commun; 2004 Mar; 316(1):85-92. PubMed ID: 15003515
[TBL] [Abstract][Full Text] [Related]
26. Direct role for Myc in transcription initiation mediated by interactions with TFII-I.
Roy AL; Carruthers C; Gutjahr T; Roeder RG
Nature; 1993 Sep; 365(6444):359-61. PubMed ID: 8377829
[TBL] [Abstract][Full Text] [Related]
27. Ketogenic HMGCS2 Is a c-Myc target gene expressed in differentiated cells of human colonic epithelium and down-regulated in colon cancer.
Camarero N; Mascaró C; Mayordomo C; Vilardell F; Haro D; Marrero PF
Mol Cancer Res; 2006 Sep; 4(9):645-53. PubMed ID: 16940161
[TBL] [Abstract][Full Text] [Related]
28. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
Li H; Wu X
Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507
[TBL] [Abstract][Full Text] [Related]
29. A role of Miz-1 in Gfi-1-mediated transcriptional repression of CDKN1A.
Liu Q; Basu S; Qiu Y; Tang F; Dong F
Oncogene; 2010 May; 29(19):2843-52. PubMed ID: 20190815
[TBL] [Abstract][Full Text] [Related]
30. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
31. c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.
Vaqué JP; Fernández-García B; García-Sanz P; Ferrandiz N; Bretones G; Calvo F; Crespo P; Marín MC; León J
Mol Cancer Res; 2008 Feb; 6(2):325-39. PubMed ID: 18314492
[TBL] [Abstract][Full Text] [Related]
32. Cell growth inhibition by okadaic acid involves gut-enriched Kruppel-like factor mediated enhanced expression of c-Myc.
Zhang L; Wali A; Ramana CV; Rishi AK
Cancer Res; 2007 Nov; 67(21):10198-206. PubMed ID: 17974960
[TBL] [Abstract][Full Text] [Related]
33. KLF2 inhibits Jurkat T leukemia cell growth via upregulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1.
Wu J; Lingrel JB
Oncogene; 2004 Oct; 23(49):8088-96. PubMed ID: 15361832
[TBL] [Abstract][Full Text] [Related]
34. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells.
Wiener Z; Ontsouka EC; Jakob S; Torgler R; Falus A; Mueller C; Brunner T
Exp Cell Res; 2004 Sep; 299(1):227-35. PubMed ID: 15302589
[TBL] [Abstract][Full Text] [Related]
35. pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF beta-receptor transcription.
Uramoto H; Hackzell A; Wetterskog D; Ballági A; Izumi H; Funa K
J Cell Sci; 2004 Aug; 117(Pt 17):3855-65. PubMed ID: 15265983
[TBL] [Abstract][Full Text] [Related]
36. c-Myc is essential for hematopoietic stem cell differentiation and regulates Lin(-)Sca-1(+)c-Kit(-) cell generation through p21.
Baena E; Ortiz M; Martínez-A C; de Alborán IM
Exp Hematol; 2007 Sep; 35(9):1333-43. PubMed ID: 17637497
[TBL] [Abstract][Full Text] [Related]
37. Src inhibits adriamycin-induced senescence and G2 checkpoint arrest by blocking the induction of p21waf1.
Vigneron A; Roninson IB; Gamelin E; Coqueret O
Cancer Res; 2005 Oct; 65(19):8927-35. PubMed ID: 16204065
[TBL] [Abstract][Full Text] [Related]
38. Induction of G1 cell cycle arrest and P15INK4b expression by ECRG1 through interaction with Miz-1.
Zhao N; Wang J; Cui Y; Guo L; Lu SH
J Cell Biochem; 2004 May; 92(1):65-76. PubMed ID: 15095404
[TBL] [Abstract][Full Text] [Related]
39. Promoter-binding and repression of PDGFRB by c-Myc are separable activities.
Mao DY; Barsyte-Lovejoy D; Ho CS; Watson JD; Stojanova A; Penn LZ
Nucleic Acids Res; 2004; 32(11):3462-8. PubMed ID: 15226411
[TBL] [Abstract][Full Text] [Related]
40. c-Abl tyrosine kinase activates p21 transcription via interaction with p53.
Jing Y; Wang M; Tang W; Qi T; Gu C; Hao S; Zeng X
J Biochem; 2007 May; 141(5):621-6. PubMed ID: 17339230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
